Skip to content
Skip over generic navigation
Skip over primary navigation
Skip over visual
Skip over functional column
Our FDA-approved site in Hanau, Germany combines an impressive production capacity with a focus on research, development and analysis.
The site has a total manufacturing capacity for APIs, HPAPIs and intermediates of 196 m³; 168 m³ are operated in accordance with current Good Manufacturing Practice (cGMP) regulations. In addition, Hanau is home to our center of excellence for strain, fermentation and process development.
Further specialist areas at our Hanau site include asymmetric synthesis, hydrogenations, Suzuki coupling, Grignard reactions and amino acid derivatives.